Form 4: Director Fernando Aguirre Sells CVS Health Shares

CVS Health Director Fernando Aguirre reported the sale of 19,924 shares of common stock across two transactions in May 2026.

Summary

• Director Fernando Aguirre disposed of a total of 19,924 shares of CVS Health common stock.
• On May 20, 2026, 18,361 shares were sold at a weighted average price of $93.775.
• On May 21, 2026, an additional 1,563 shares were sold at a price of $93.501.
• Following these transactions, the director retains beneficial ownership of 10,513 shares of CVS Health common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the filing reflects routine insider activity rather than a strategic change or financial distress.

Positives

• The transactions represent standard portfolio management by a company director.

Negatives

• The sale of shares by an insider may be perceived by some market participants as a lack of confidence in near-term price appreciation.

Risks

• None identified in this filing.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that director share sales are common occurrences in large-cap healthcare companies and are often related to personal financial planning rather than company-specific fundamental shifts.

Comparison to Industry Standards

• Insider selling activity at CVS Health remains consistent with historical patterns for S&P 500 healthcare directors.

Stakeholder Impact

• Minimal impact expected on shareholders as the volume sold represents a small fraction of total outstanding shares.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

CVS Health, Insider Trading, Form 4, Fernando Aguirre, Stock Sale